scout
Opinion|Videos|December 20, 2023

Recent Data on Anti-TROP2 ADCs for Patients With Advanced or Recurrent Endometrial Cancer

The panel highlights recent data on antibody drug conjugates targeting TROP2 in patients with advanced or recurrent endometrial cancer and the need for dose optimization.

Episodes in this series

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME